Physician

Aditya R Bansal, MD

According to 2025 Medicare claims, Aditya Bansal, MD (NPI: 1720064546) practices critical care (intensivists) in the Atlantic City-Hammonton, NJ market, with the plurality of this provider's patient population coming from Atlantic, NJ. This provider's primary affiliated billing organization is ATLANTICARE PHYSICIAN GROUP PA (NPI: 1093829608; TIN: 020701782) and primary practice location at 08205-9438. Bansal is affiliated with the AtlantiCare Health Solutions, Inc. (ACO ID: A4516), participating under the MSSP model.

Bansal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 572 traditional Medicare patients, billed 1,590 HCPCS/CPT codes, and received $102,172 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 2,074 prescription claims across 372 beneficiaries totaling $850,350 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 1,315 claims. Open Payments data shows 93 records totaling $1,818. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $181,578 to $102,172. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $127,242 to $850,350. For DME billing, reported payments moved sharply higher in recent years, from $46,247 to $75,755.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	788	1,918	$181,578
2016	804	2,149	$175,599
2017	833	2,117	$183,064
2018	869	2,285	$194,662
2019	875	2,191	$182,018
2020	703	1,665	$152,101
2021	605	1,491	$139,212
2022	529	1,225	$112,270
2023	580	1,363	$125,473
2024	572	1,590	$102,172

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	163	503	$127,242
2016	173	529	$136,414
2017	149	619	$147,820
2018	187	706	$157,169
2019	194	855	$280,619
2020	211	1,197	$541,237
2021	214	1,096	$631,860
2022	227	1,204	$548,695
2023	268	1,481	$680,379
2024	372	2,074	$850,350

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	222	678	$53,588
2016	279	1,024	$57,724
2017	192	809	$35,372
2018	266	907	$42,232
2019	302	1,110	$51,977
2020	339	1,359	$96,956
2021	305	1,225	$72,744
2022	399	1,351	$124,184
2023	377	1,493	$110,008
2024	426	1,315	$92,378

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	158	167	$125
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	158	242	$91
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	155	179	$65
94060	Test to measure expiratory airflow and volume changes before and after medication administration	151	154	$26
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	159	194	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	298	14,520	$297,434
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	82	3,570	$72,057
Dupixent Pen	Dupilumab	18	490	$67,039
Breo Ellipta	Fluticasone/Vilanterol	116	4,860	$61,445
Pirfenidone	Pirfenidone	14	617	$56,940

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	15	$12,861
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	12	$12,136
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	29	179	$12,048
E0483	High frequency chest wall oscillation system, with full anterior and/or posterior thoracic region receiving simultaneous external oscillation, includes all accessories and supplies, each	Y	N/R	11	$9,601
A4604	Tubing with integrated heating element for use with positive airway pressure device	N	58	127	$4,484

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	93	$1,818	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aditya R. Bansal, MD?

Tedicare shows public-source Medicare data for Aditya R. Bansal, MD (NPI 1720064546), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aditya R. Bansal, MD have ACO affiliation data?

Aditya R. Bansal, MD is shown with ACO affiliation data for AtlantiCare Health Solutions, Inc. (MSSP, ACO ID A4516).

What billing organization is linked to Aditya R. Bansal, MD?

Aditya R. Bansal, MD is linked to ATLANTICARE PHYSICIAN GROUP PA (billing NPI 1093829608) in the available physician profile data.

Does Aditya R. Bansal, MD have Open Payments data?

Aditya R. Bansal, MD has 93 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.